Are allergy drops safe? Is there research validating their effectiveness?

Allergy drops have been used around the world for more than 100 years, and numerous studies validate both its safety and effectiveness. In fact, the World Health Organization has endorsed sublingual immunotherapy as a viable alternative to allergy shot therapy. The Cochrane Collaboration, the world’s most-trusted international organization dedicated to reviewing healthcare treatments, concluded that allergy drop immunotherapy significantly reduced allergy symptoms and medication use.

In 2013, the Agency for Healthcare Quality Research published a review that examined studies which used both sublingual and subcutaneous immunotherapy (allergy shot) treatments. Reviewers found sufficient evidence to support the effectiveness and safety of subcutaneous and sublingual immunotherapy for the treatment of allergic rhinitis (hay fever) and asthma.

In addition, La Crosse Method Protocol outcomes have been validated through the Validation Institute, an independent team of population health scientists and bio-statisticians who provide objective review to validate performance in healthcare.

See our bibliography for more information about research studies.